serine/threonine Kinase 17a (STK17A) (N-Term) Peptide
STK17A
适用: 人
BP
Sodium azide
-
- 抗原 See all STK17A products
- STK17A (serine/threonine Kinase 17a (STK17A))
- 蛋白结构域
- N-Term
- 宿主
- 人
- 应用范围
- Blocking Peptide (BP)
- 产品特性
-
15 amino amino terminus of human DRAK1.
Human
-
-
- 应用备注
- DRAK1 peptide is used for blocking the activity of DRAK1.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 200 μg/mL
- 缓冲液
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 有效期
- 12 months
-
- 抗原
- STK17A (serine/threonine Kinase 17a (STK17A))
- 别名
- STK17A Peptide, DRAK1 Peptide, RDRAK1 Peptide, serine/threonine kinase 17a Peptide, serine/threonine kinase 17a L homeolog Peptide, STK17A Peptide, stk17a Peptide, stk17a.L Peptide
-
You are here:
